TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
UPB

Upstream Bio, Inc.

Healthcare · Biotechnology · —

5.20$ -5.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet UPB
Line item 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0%
99.1% 99.8% 99.5% 99.4%
92.3% 22.0% 67.7% 28.7%
92.3% 93.7% 97.7% 96.5%
2.2% 0.2% 0.2% 0.2%
674.5% 205.1% 2.5% 4.0%
26.3% 5.6% 2.2% 3.8%
0.5% 0.0% 0.1% 0.2%
3.9% 1.7% 0.8% 0.8%
-574.5% -105.1% 97.5% 96.0%
-581.4% -109.2% -39.6% -94.5%
196.6% 31.0% 10.7% 15.2%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?